AT

Abhishek Tusharkant Katakwar

Active Director Director DIN 11318104
DIN 11318104 First appointment Sep 2025 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Abhishek Tusharkant Katakwar

Data last updated:

Abhishek Tusharkant Katakwar is a Director at Padma Health Care Private Limited (since 2025). The company operates in Healthcare.

DIN 11318104
Primary Designation Director
Industry Healthcare
First Appointment 26 Sep 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Padma Health Care Private Limited U46596TS2025PTC204521
Director26 Sep 20252025Active

Board colleagues of Abhishek Tusharkant Katakwar

NameDINCompanyDesignation
Aparna Murali Rao11318103Padma Health Care Private LimitedDirector

Directorship timeline

Open interactive timeline →
Padma Health Care Private Limited
Premium access

Shareholding and investment profile for Abhishek Tusharkant Katakwar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abhishek Tusharkant Katakwar

Abhishek Tusharkant Katakwar currently holds 1 directorship: Padma Health Care Private Limited (Director, since 26 Sep 2025).

Abhishek Tusharkant Katakwar was first appointed on 26 Sep 2025 as Director at Padma Health Care Private Limited.

The current boards of Abhishek Tusharkant Katakwar's companies include Aparna Murali Rao (Padma Health Care Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available